• Sign up to our Free Newsletter
  • Contact Us
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Editor’s Choice

Editor's Choice

New standards in sensitivity and accuracy for microbiome research

September 20, 2023 Microbiome Times

Microbiome research promises to transform human health; however, until now the field has been held back by the challenges of translating microbiome data into novel treatments, ingredients, diagnostics, and other healthcare solutions. A number of […]

Editor's Choice

Integrating Microbiome and Dietary Data: Microbiome Data Congress 2023

August 22, 2023 Daniel Quinn

The composition and metabolic output of the human gut microbiome is shaped by several environmental factors, an important one being diet. To better understand the relationship between diet and microbiome function researchers must develop methods […]

Editor's Choice

Distinguishing Strains in Microbiome Samples: Considerations and Challenges

July 19, 2023 Daniel Quinn

Defining the term “strain” is a conscientious issue within the microbiome field. Broadly speaking, a bacterial strain is a sub-group within a species with unique characteristics such as genetic makeup, metabolism, and morphology. But standards […]

Editor's Choice

Proven Complementary Effect of Probiotic Yeast and Bacteria

June 21, 2023 Romane Maillet

  Yeast and bacteria combination for the best of both worlds Yeast and bacteria have been successfully used as probiotic for decades: bacteria, mainly from the Lactobacilli and Bifidobacteria species; and yeast Saccharomyces cerevisiae var. […]

Editor's Choice

Microbiome drug development: Analysis of the historical pipeline reveals promising areas and bottlenecks

May 25, 2023 Luis Gosálbez

Abstract Microbiome drug development has captured significant interest over the last decade. However, despite the recent clinical and regulatory success stories, this area is lately regarded as a high-risk one by investors given the current […]

Editor's Choice

DNA Genotek enables development of microbiome-based clinical applications with OMNIgene™•GUT Dx – the first and only FDA-authorized fecal self-collection device

May 10, 2023 Sanna Abbasi, Ph.D.

Historically, researchers have surveyed the composition and/or expression of microorganisms within the human gut microbiome by collecting fecal samples, isolating microbial nucleic acids, and using those nucleic acids to analyze the microbial species present within […]

Editor's Choice

Seres Therapeutics and Nestlé Health Science Announce FDA Approval of VOWST™

April 27, 2023 Microbiome Times

Seres Therapeutics, Inc. (Nasdaq: MCRB) and Nestlé Health Science today announced the U.S. Food and Drug Administration (FDA) approval of VOWSTTM (fecal microbiota spores, live-brpk), formerly called SER-109, an orally administered microbiota-based therapeutic to prevent recurrence of C. difficile Infection (CDI) in adults […]

Editor's Choice

Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies

April 25, 2023 Microbiome Times

Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral therapies based on defined bacterial consortia, today announced that it has raised $106.5 million to support pivotal-stage development of its lead […]

Editor's Choice

Researchers create virus-resistant, safely restrained E. coli

April 10, 2023 Microbiome Times

In a step forward for genetic engineering and synthetic biology, researchers have modified a strain of Escherichia coli bacteria to be immune to natural viral infections while also minimizing the potential for the bacteria or their modified […]

Editor's Choice

“Probiotics” Green-lit for market-usage by French Authorities

January 25, 2023 Microbiome Times

In a letter to the National Union of Food Supplements, the Direction générale de la consommation, de la concurrence et de la répression des fraudes (DGCCRF) outlined that supplements can use the term so long […]

Editor's Choice

Microbiome Drug Development: 2022 in Review

December 30, 2022 Luis Gosálbez

Leveraging a year of important research updates, funding rounds, and academic papers, this report compiles the most significant industry news pertaining to microbiome drug development in 2022. It finds that the regulatory approval of three […]

Posts navigation

1 2 … 11 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • New standards in sensitivity and accuracy for microbiome research
    September 20, 2023
  • Integrating Microbiome and Dietary Data: Microbiome Data Congress 2023
    August 22, 2023
  • Distinguishing Strains in Microbiome Samples: Considerations and Challenges
    July 19, 2023
  • Proven Complementary Effect of Probiotic Yeast and Bacteria
    June 21, 2023
  • Microbiome drug development: Analysis of the historical pipeline reveals promising areas and bottlenecks
    May 25, 2023
sign up

Sign up to the Microbiome Times newsletter